XXXX treated with photodynamic therapy using @entity4936 .

@entity1018 @entity1 @entity4936 @entity5 @entity3193 @entity941
OBJECTIVE: To describe a new treatment for @entity1018 caused by subretinal fluid associated with circumscribed @entity3193 . METHODS: Three @entity1 were treated with photodynamic therapy using @entity4936 for injection ( @entity4936 ; QLT Phototherapeutics Inc, Vancouver, British Columbia). All @entity1 had pretreatment and posttreatment @entity941 angiography and ultrasonography. Treatment parameters used were @entity4936 , 6 mg/m(2), and laser light at 689 nm delivered at 50 J/cm(2) with an intensity of 600 mW/cm(2) for 83 seconds. RESULTS: All @entity1 had complete resolution of subretinal fluid within 2 weeks of treatment. Fluorescein angiography performed 2 to 4 weeks after treatment showed absence of @entity5 leakage. All eyes had reduced @entity5 thickness or complete flattening. Visual acuity was improved in each eye. Average follow-up was 5.3 months. No complications were noted. CONCLUSION: Photodynamic therapy with @entity4936 is effective in eliminating subretinal fluid and improving vision in @entity1 with circumscribed @entity3193 .
